Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.

Böhm, Michael; Butler, Javed; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Abdin, Amr; Mahfoud, Felix; Brueckmann, Martina; Gollop, Nicholas D; Iwata, Tomoko; +6 more... Ponikowski, Piotr; Wanner, Christoph; Zannad, Faiez; Packer, Milton; Anker, Stefan D; EMPEROR-Preserved Trial Committees and Investigators; (2022) Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age. Journal of the American College of Cardiology, 80 (1). pp. 1-18. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2022.04.040

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2022.04.040

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 35772911
Elements ID 181155

Share

Download

Filename: 1-s2.0-S0735109722049373-main.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar